Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CHRS
STIM
Add up to 3 more stocks
CHRS
Coherus Oncology, Inc.
-8.04%
$1.03-0.09Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$159.14M
52W Range
$1.08 - $2.62
STIM
Neuronetics, Inc.
+0.45%
$2.21+0.01Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$153.79M
52W Range
$0.80 - $3.44
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.62 | 8.62 |
| P/S Ratio | 3.12 | 0.99 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 63.5% | 49.1% |
| Operating Margin | -425.7% | -14.7% |
| Net Margin | -257.1% | -19.6% |
| ROE | -215.3% | -170.5% |
| ROA | -68.5% | -23.1% |
| ROIC | -135.4% | -22.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.77 | 1.88 |
| Quick Ratio | 1.70 | 1.69 |
| Debt/Equity | 0.62 | 4.85 |
| Interest Coverage | -19.95 | -3.74 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.